Saamya Biotech India informs about quarterly statement of investor complaints

06 Apr 2016 Evaluate

Saamya Biotech India has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1721.05
Dr. Reddys Lab 1251.65
Cipla 1500.90
Zydus Lifesciences 914.00
Lupin 2102.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×